Depending on the patients individual health profile, the medication is effective enough to show results in many patients within the first month of treatment
By targeting appetite, blood sugar, and metabolism, they offer an alternative weight loss solution that supports steady progress, especially when paired with lifestyle changes and clinical oversight
FDA-approved escalation for weight management (Wegovy protocol) *Exceeds standard 100-unit syringe capacity
But if you go back and look at those early studies, you see them reporting a decent amount of weight loss [from the drug]. It wasnt until years later that liraglutide, another GLP-1 agonist, was approved for both diabetes and obesity, albeit under two different brand names: Victoza for diabetes and Saxenda for obesity
One missed dose may not affect you much, but consistently missing doses could affect you in the long run